Yazipo D, Ngaindiro L F, Barrière-Constantin L, Namboua L, Pichard E, Ndoyo J, Bourdoux P
Ministère de la Santé publique, Direction de la médecine préventive et des grandes endémies, Bangui, République Centrafricaine.
Sante. 1995 Jan-Feb;5(1):9-17.
Iodine deficiency disorders are major problems in most developing countries. According to WHO more than one billion people worldwide are at risk for iodine deficiency. However, prophylaxis programs based on the distribution of iodized salt have been unsuccessful in developing countries for socioeconomic reasons. We tested the efficacy of iodination of water with sodium iodide incorporated into silicone matrices (Rhône-Poulenc-Rorer-Doma). Nine such matrices were placed into each of the 198 wells supplying more than 90% of the 85,037 inhabitants of the Nana-Grebizi prefecture (figure 1). Efficacy was evaluated by following classical markers of iodine deficiency in representative samples of the population (figure 2): goiter size was measured immediately before (T = 0, n = 3,090) and twelve months after (T = 12, n = 2,645) installation of the matrices; and urinary iodine concentrations were assayed at T = 0 (n = 319), 6 (n = 304) and 12 (n = 261). The prevalence of goiter was 60.9% (visible goiter 10.7%, cretinism 0.7%) and the median urinary iodine concentration was 2.1 (95% confidence interval 2.0-2.3) micrograms/dl. Thus the population suffered from severe iodine deficiency. All villages were severely affected, despite inter-village variations (tables 1 and 2, figure 4). Twelve months after iodination of wells, the overall prevalence of goiter fell to 44.5% (p < 0.0001, table 1 and figure 3) and that of visible goiter to 2.5% (p < 0.0001). With the exception of one village (Bokanzi) the prevalence of goiter decreased by 18.6 to 56.3% (table 1).(ABSTRACT TRUNCATED AT 250 WORDS)
碘缺乏症是大多数发展中国家面临的主要问题。据世界卫生组织称,全球超过10亿人面临碘缺乏风险。然而,由于社会经济原因,在发展中国家基于碘盐分发的预防计划并不成功。我们测试了将碘化钠掺入硅酮基质(罗纳 - 普朗克 - 罗瑞尔 - 多马)对水进行碘化处理的效果。在为纳纳 - 格雷比齐省85,037名居民中90%以上人口供水的198口水井中,每口井放置9个这样的基质(图1)。通过跟踪该人群代表性样本中碘缺乏的经典指标来评估效果(图2):在安装基质之前(T = 0,n = 3,090)和之后十二个月(T = 12,n = 2,645)立即测量甲状腺肿大小;并在T = 0(n = 319)、6(n = 304)和12(n = 261)时检测尿碘浓度。甲状腺肿患病率为60.9%(可见甲状腺肿10.7%,克汀病0.7%),尿碘浓度中位数为2.1(95%置信区间2.0 - 2.3)微克/分升。因此,该人群存在严重碘缺乏。尽管各村之间存在差异(表1和表2,图4),但所有村庄都受到严重影响。水井碘化处理十二个月后,甲状腺肿总体患病率降至44.5%(p < 0.0001,表1和图3),可见甲状腺肿患病率降至2.5%(p < 0.0001)。除了一个村庄(博坎齐)外,甲状腺肿患病率下降了18.6%至56.3%(表1)。(摘要截断于250字)